RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy
Microcirculation · 2022-11 · 29 (8)
DOI: 10.1111/micc.12790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microcirculation, online erschienen am 14.10.2022. Verfasst von Annalinda Pisano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Myocardial Ischemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Coronary microvascular dysfunction (CMD) is a key pathophysiological feature of hypertrophic cardiomyopathy (HCM), contributing to myocardial ischemia and representing a critical determinant of patients' adverse outcome. The molecular mechanisms underlying the morphological and functional changes of CMD are still unknown. Aim of this study was to obtain insights on the molecular pathways associated with microvessel remodeling in HCM.
Methods
Interventricular septum myectomies from patients with obstructive HCM ( n = 20) and donors' hearts (CTRL, discarded for technical reasons, n = 7) were collected. Remodeled intramyocardial arterioles and cardiomyocytes were microdissected by laser capture and next‐generation sequencing was used to delineate the transcriptome profile.
Results
We identified 720 exclusive differentially expressed genes (DEGs) in cardiomyocytes and 1315 exclusive DEGs in remodeled arterioles of HCM. Performing gene ontology and pathway enrichment analyses, we identified selectively altered pathways between remodeled arterioles and cardiomyocytes in HCM patients and controls.
Conclusions
We demonstrate the existence of distinctive pathways between remodeled arterioles and cardiomyocytes in HCM patients and controls at the transcriptome level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
- Italian National Institute of Health (ISS), Core Facilities, Rome, Italy.
- National Research Council (IBIOM-CNR), Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Bari, Italy.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- Department of Chemistry and Drug Technologies, Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Pisano, A., Pera, L. L., Carletti, R., Cerbelli, B., Pignataro, M. G., Pernazza, A., Ferre, F., Lombardi, M., Lazzeroni, D., Olivotto, I., Rimoldi, O. E., Foglieni, C., Camici, P. G., & d'Amati, G. (2022). RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy. Microcirculation, 29(8). https://doi.org/10.1111/micc.12790
Vancouver
Pisano A, Pera LL, Carletti R, Cerbelli B, Pignataro MG, Pernazza A, et al. RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy. Microcirculation. 2022;29(8). doi:10.1111/micc.12790
BibTeX
@article{Pisano2022,
author = {Pisano, Annalinda and Pera, Loredana Le and Carletti, Raffaella and Cerbelli, Bruna and Pignataro, Maria G and Pernazza, Angelina and Ferre, Fabrizio and Lombardi, Maria and Lazzeroni, Davide and Olivotto, Iacopo and Rimoldi, Ornella E and Foglieni, Chiara and Camici, Paolo G and d'Amati, Giulia},
title = {RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy},
journal = {Microcirculation},
year = {2022},
volume = {29},
number = {8},
doi = {10.1111/micc.12790}
}
EUVIMED